Generation Bio Co. (GBIO)

1.3900 +0.2600 (+23.01%) At close: 04:00PM EST

Generation Bio Co.

301 Binney Street
Cambridge, MA 02142
United States
617 655 7500
https://generationbio.com

Sector(s): Healthcare
Industry: Biotechnology
Full Time Employees: 150

Key Executives

Name	Title	Pay	Exercised	Year Born
Dr. Cameron Geoffrey McDonough M.D.	President, CEO & Director	939.09k	N/A	1970
Dr. Matthew Norkunas M.B.A., M.D.	Chief Financial Officer	611.11k	N/A	1978
Dr. Matthew Stanton Ph.D.	Chief Scientific Officer	654.83k	N/A	1973
Dr. Douglas Kerr M.B.A., M.D., Ph.D.	Chief Medical Officer	659.1k	N/A	1967
Dr. Tracy Zimmermann Ph.D.	Chief Development Officer	622.74k	N/A	1970
Dr. Mark D. Angelino Ph.D.	Co-Founder	N/A	N/A	1973
Dr. Robert Kotin Ph.D.	Co-Founder	N/A	N/A	1956
Ms. Antoinette Paone M.B.A., M.S.	Chief Operating Officer	N/A	N/A	1978
Ms. Yalonda Howze J.D.	Chief Legal Officer & Secretary	N/A	N/A	1972
Ms. Jasmin Tower	Senior Vice President of People & Operations	N/A	N/A	N/A

Amounts are as of December 31, 2022 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Generation Bio Co., a genetic medicines company, develops therapies for the treatment of rare and prevalent diseases. The company provides a portfolio of programs, including programs for rare and prevalent diseases of the liver and retina. It also focuses on the diseases of skeletal muscle, central nervous system, and oncology. The company was formerly known as Torus Therapeutics, Inc. and changed its name to Generation Bio Co. in November 2017. Generation Bio Co. was incorporated in 2016 and is headquartered in Cambridge, Massachusetts.

Corporate Governance

Generation Bio Co.’s ISS Governance QualityScore as of December 1, 2023 is 8. The pillar scores are Audit: 8; Board: 8; Shareholder Rights: 8; Compensation: 8.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.